Favipiravir: A new and emerging antiviral option in COVID-19
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference28 articles.
1. Favipiravir (T-705), a novel viral RNA polymerase inhibitor;Furuta;Antivir Res,2013
2. Toyama Chemicals. Summary of Product Characteristics of Avigan.
3. Ebola virus infection: review of the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials;Madelain;Clin Pharmacokinet,2016
4. The ambiguous base-pairing and high substrate efficiency of T-705 (favipiravir) ribofuranosyl 5′-triphosphate towards influenza A virus polymerase;Jin;PloS One,2013
5. 705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro;Baranovich;J Virol,2013
Cited by 300 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Green solvents tailored nanostructures of block copolymers and their potential applications in drug delivery;Journal of Molecular Liquids;2024-09
2. Enhancing therapeutic efficacy and safety profile of Favipiravir through noble metal loaded silica nanocomposites: A quantum chemical and molecular docking study for COVID-19 treatment;Journal of Organometallic Chemistry;2024-09
3. Synthesis, characterization, DFT and molecular docking study of an antiviral drug, the crystallized 6-methoxylated derivative of favipiravir, in the presence of an iron (III) Lewis acid.;Journal of Molecular Structure;2024-09
4. Predictive Modelling of 6-Fluoro-3-Hydroxy-2-Pyrazine Carboxamide Drug Delivery Efficacy in Pegylated Bionanocomposite Through First Principles Simulation;2024-08-23
5. Assessing the impact of antiviral drugs commonly utilized during the COVID-19 pandemic on the embryonic development of Xenopus laevis;Journal of Hazardous Materials;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3